Innovative Oncology Focus NETRIS Pharma specializes in developing first-in-class therapeutics targeting Netrin-1, a key player in tumor progression, positioning it as a leader in innovative cancer treatments that appeal to hospitals and oncological research centers seeking cutting-edge solutions.

Strategic Industry Position Situated within the Léon Bérard Cancer Center and actively participating in prominent conferences like ESMO Congress, NETRIS Pharma demonstrates strong connections with top cancer research institutions, creating opportunities to collaborate or supply advanced biotechnologies for clinical trials.

Recent Funding & Growth With over 8 million USD in recent funding and a growing pipeline including treatments for cancer and endometriosis, NETRIS Pharma is expanding its portfolio, providing potential for partnerships or sales of novel therapeutic molecules and related research tools.

Leadership & Talent Acquisition Key hires such as a new Chief Medical Officer and independent directors signify active leadership development and strategic growth, indicating an openness to collaborations that can leverage their expanding expert team in clinical research and drug development.

Recognition & Credibility Awarded for their biotech pitch and involved in high-profile investor days, NETRIS Pharma’s proven credibility and visibility in the biotech industry offer opportunities for investors, suppliers, and service providers looking to partner with a fast-growing innovative company.